Medtronic Neuromodulation7000 Central Avenue N E Minneapolis Mn 55432 Pma Numberp970004 Supplement Numbers374 Date Received09 27 2022 Decision Date10 27 2022 Product Code Ezw Advisory Committee Gastroenterology Urology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Medtronic Neuromodulation7000 Central Avenue N E Minneapolis Mn 55432 Pma Numberp970004 Supplement Numbers374 Date Received09 27 2022 Decision Date10 27 2022 Product Code Ezw Advisory Committee Gastroenterology Urology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P970004S374 MEDTRONIC NEUROMODULATION7000 Central Avenue, N.e.minneapolis, MN 55432 PMA NumberP970004 Supplement NumberS374 Date Received09/27/2022 Decision Date10/27/2022 Product Code EZW  Advisory Committee Gastroenterology/Urology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	InterStim® Therapy System, Verify® Evaluation System	2022-10-27